Cargando…
Axl‐inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model
Renal fibrosis is a progressive histological manifestation leading to chronic kidney disease (CKD) and associated with mitochondrial dysfunction. In previous work, we showed that Bemcentinib, an Axl receptor tyrosine kinase inhibitor, reduced fibrosis development. In this study, to investigate its e...
Autores principales: | Hoel, August, Osman, Tarig, Hoel, Fredrik, Elsaid, Hassan, Chen, Tony, Landolt, Lea, Babickova, Janka, Tronstad, Karl Johan, Lorens, James B., Gausdal, Gro, Marti, Hans‐Peter, Furriol, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335678/ https://www.ncbi.nlm.nih.gov/pubmed/34219376 http://dx.doi.org/10.1111/jcmm.16769 |
Ejemplares similares
-
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
por: Landolt, Lea, et al.
Publicado: (2019) -
AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model
por: Chen, Tony J., et al.
Publicado: (2021) -
Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla(−/−) zebrafish model of Fabry disease
por: Elsaid, Hassan Osman Alhassan, et al.
Publicado: (2023) -
Gene Expression Analysis in gla-Mutant Zebrafish Reveals Enhanced Ca(2+) Signaling Similar to Fabry Disease
por: Elsaid, Hassan Osman Alhassan, et al.
Publicado: (2022) -
Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)